Alzheimer's Association President and CEO Harry Johns said the vote was disappointing, claiming publicly released data on aducanumab justified its federal approval.
Leaders with the Los Angeles-based outpatient imaging giant partially credited “aggressive" cost containment measures for their rosier financial picture.
As Joe Biden makes plans to intensify the federal response to the COVID crisis, he can expect support on that agenda item from 77% of Democrats, 62% of independents, 55% of Republicans and 50% of others.
A university, health system and tech giant are piloting the use of deep learning with IoT and edge computing to block COVID-19 from infiltrating a 548-bed hospital.